Valerie Palmieri was appointed President and Chief Executive Officer in January 2015, prior to joining Aspira Women's Health as Chief Operating Officer in October 2014. During her tenure at Aspira Women’s Health Valerie led the transition of the company to the commercialization of its market-leading products and is now focused on the company’s product expansion pipeline into benign pelvic mass management and endometriosis.